Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.694
+0.018 (2.65%)
At close: Dec 20, 2024, 4:00 PM
0.708
+0.014 (1.97%)
After-hours: Dec 20, 2024, 4:46 PM EST

Verrica Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
63308113252298410
Upgrade
Market Cap Growth
-62.05%172.47%-55.17%-15.33%-27.31%95.57%
Upgrade
Enterprise Value
8726775216263339
Upgrade
Last Close Price
0.697.322.759.1611.5115.89
Upgrade
PS Ratio
3.5160.0912.5121.01--
Upgrade
PB Ratio
-1.8215.582.827.739.036.30
Upgrade
P/TBV Ratio
-15.582.827.739.036.30
Upgrade
EV/Sales Ratio
9.4552.198.3217.98--
Upgrade
Debt / Equity Ratio
-1.382.300.041.331.130.00
Upgrade
Asset Turnover
0.140.080.140.16--
Upgrade
Quick Ratio
1.104.3410.051.531.6618.51
Upgrade
Current Ratio
1.344.5511.311.611.7119.39
Upgrade
Return on Equity (ROE)
-2059.89%-224.08%-67.42%-106.97%-87.13%-36.53%
Upgrade
Return on Assets (ROA)
-71.41%-62.56%-21.32%-25.04%-35.23%-23.45%
Upgrade
Return on Capital (ROIC)
-93.65%-73.97%-22.64%-26.42%-37.10%-24.32%
Upgrade
Earnings Yield
-135.19%-21.76%-21.67%-13.92%-14.34%-6.89%
Upgrade
FCF Yield
-94.84%-12.65%-16.77%-11.29%-10.64%-6.86%
Upgrade
Buyback Yield / Dilution
-5.62%-32.72%-26.32%-8.20%-0.39%-69.80%
Upgrade
Total Shareholder Return
-5.62%-32.72%-26.32%-8.20%-0.39%-69.80%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.